MicroRNAs in atrial fibrillation – have we discovered the Holy Grail or opened a Pandora’s box?
Atrial fibrillation (AF) causes a heavy socio-economic burden on healthcare systems around the globe. Identification of new preventive, diagnostic, and treatment methods is imperative. In recent years, special attention has been paid to microRNAs (miRNAs) as potential regulators of AF pathogenesis....
Saved in:
Main Authors: | Alkora Ioana Balan, Alina Scridon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1535621/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions
by: Emmanouil P. Vardas, et al.
Published: (2024-12-01) -
Influence of catheter ablation for atrial fibrillation on atrial and ventricular functional mitral regurgitation
by: Masaharu Masuda, et al.
Published: (2022-06-01) -
Atrial Cardiomyopathy: From Diagnosis to Treatment
by: Zheyu Liu, et al.
Published: (2025-01-01) -
Hypermethylation of Hif3a and Ifltd1 is associated with atrial remodeling in pressure-overload murine model
by: Keiko Abe, et al.
Published: (2025-01-01) -
The effect of continuous positive airway pressure therapy on atrial fibrillation in patients with obstructive sleep apnea
by: Jiancheng Hu, et al.
Published: (2025-01-01)